In Brief: FSMA Rules Proposed | One-Step Exclusivity | Early At CHPA | EU Clears NovaTears
This article was originally published in The Tan Sheet
Executive Summary
FSMA auditing, supplier verification rules proposed; Plan B One-Step gets OTC exclusivity until 2016; Early joins CHPA as VP, CFO; Novaliq’s NovaTears Gains EU approval; and Senate bill boosts NIH appropriation.